Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
Guardado en:
Autores principales: | Min Thura, Abdul Qader Al-Aidaroos, Abhishek Gupta, Cheng Ean Chee, Soo Chin Lee, Kam Man Hui, Jie Li, Yeoh Khay Guan, Wei Peng Yong, Jimmy So, Wee Joo Chng, Chin Hin Ng, Jianbiao Zhou, Ling Zhi Wang, John Shyi Peng Yuen, Henry Sun Sien Ho, Sim Mei Yi, Edmund Chiong, Su Pin Choo, Joanne Ngeow, Matthew Chau Hsien Ng, Clarinda Chua, Eugene Shen Ann Yeo, Iain Bee Huat Tan, Joel Xuan En Sng, Nicholas Yan Zhi Tan, Jean Paul Thiery, Boon Cher Goh, Qi Zeng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f8ffb83b0f494741802b21338c674764 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Min Thura, et al.
Publicado: (2019) -
PRL3 induces polypoid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Min Thura, et al.
Publicado: (2021) -
Author Correction: PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Min Thura, et al.
Publicado: (2021) -
Las primarias en el PRl: recuento de un experimento /
por: Casillas Ortega, Carlos
Publicado: (2000) - PRL, La Primera Revista Latinoamericana de Libros